Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. » CME http://www.diabetesincontrol.com News and information for Medical Professionals. News and information for Medical Professionals. News and information for Medical Professionals. Tue, 11 Jul 2017 17:00:12 +0000 en-US hourly 1 http://wordpress.org/?v=4.1.1 Free CME – A Comprehensive Perspective on Insulin Replacement for Type 2 Diabetes http://www.diabetesincontrol.com/free-cme-a-comprehensive-perspective-on-insulin-replacement-for-type-2-diabetes/ http://www.diabetesincontrol.com/free-cme-a-comprehensive-perspective-on-insulin-replacement-for-type-2-diabetes/#comments Wed, 11 Nov 2015 21:50:12 +0000 http://www.diabetesincontrol.com/?p=37781 Four sessions covering: Indications for initiating insulin replacement therapy in type 2 diabetes; post-prandial hyperglycemia effect on A1C; ADA/EASD recommendation for “A1C trigger level” for treatment intensification; pharmacokinetics and place in therapy of available insulin products; strategies for individualizing insulin regimens.]]> Four sessions covering: Indications for initiating insulin replacement therapy in type 2 diabetes; post-prandial hyperglycemia effect on A1C; ADA/EASD recommendation for “A1C trigger level” for treatment intensification; pharmacokinetics and place in therapy of available insulin products; strategies for individualizing insulin regimens.]]>

LIVE ACTIVITY
Thursday, November 12, 2015 from 12:00PM EST to 1:00PM EST

Enduring Material
The enduring material will be available from March 11, 2015 to March 17, 2016.

INTENDED AUDIENCE
This activity is intended for US-based primary care physicians, diabetologists, endocrinologists, diabetes educators, and other healthcare providers involved in the diagnosis, treatment, and management of patients with T2DM.

ESTIMATED TIME TO COMPLETE
This activity consists of four sessions, each which should take approximately 1 hour to complete.

SESSION TOPICS
• Indications for initiating insulin replacement therapy in type 2 diabetes
• Post-prandial hyperglycemia effect on A1C
• ADA/EASD recommendation for “A1C trigger level” for treatment intensification
• Pharmacokinetics and place in therapy of available insulin products
• Strategies for individualizing insulin regimens		 FEATURED SPEAKERS
Nancy Bohannon, MD
St. Luke’s HospitalMark E. Molitch, MD
Northwestern University Feinberg School of Medicine

Watch insulin experts live online via streaming video, participate in real-time Q&A, and earn AMA PRA Category 1 Credits™

 

]]> http://www.diabetesincontrol.com/free-cme-a-comprehensive-perspective-on-insulin-replacement-for-type-2-diabetes/feed/ 0